Electroconvulsive Monotherapy in the Treatment of Acute Confusion Psychosis

This report focuses on the successful treatment of a most acute case of confusion psychosis according to the concept of Karl Leonhard. The 18-year-old patient was hospitalized three times before the current episode and his case has been characterized as pharmacologically treatment-resistant psychosis since he failed to respond to any psychopharmacological therapy including sufficient clozapine medication. In the patient’s history, typical and atypical antipsychotic as well as mood-stabilizing and sedating pharmacological treatments have been conducted. However, only adverse effects could be observed. When receiving electroconvulsive monotherapy (ECT), the patient showed a marked reduction of symptoms while experiencing no adverse effects. The implications of this finding are discussed with regard to Leonhard’s diagnostic system.

References

• 1 American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders DSM-IV-TR. 4th edition, text revision Washington, D.C; American Psychiatric Association 2000
• 2 Beckmann H, Fritze J, Lanczik M. Prognostic validity of the cycloid psychoses: A prospective follow-up study.  Psychopathology. 1990;  23 205-211
• 3 Bender S, Grohmann R, Engel R R, Degner D, Dittmann-Balcar A, Ruther E. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.  Pharmacopsychiatry. 2004;  37 (Suppl 1) S46-53
• 4 Dietrich D E, Gödecke-Koch T, Richter-Witte C, Emrich H M. Lamotrigine in the treatment of confusion psychosis - a case report.  Pharmacopsychiatry. 2004;  37 88-90
• 5 Dietz A, Frölich L. Mefloquine-induced paranoid psychosis and subsequent major depression in a 25-year-old student.  Pharmacopsychiatry. 2002;  35 200-202
• 6 D’Souza D C, Abi-Saab W M, Madonick S, Forselius-Bielen K, Doersch A, Braley G, Gueorguieva R, Cooper T B, Krystal J H. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.  Biol Psychiatry. 2005;  57 594-608
• 7 Franzek E, Beckmann H. Different genetic background of schizophrenia spectrum psychoses: A twin study.  Am J Psychiatry. 1998;  155 76-83
• 8 Jabs B E, Pfuhlmann B, Bartsch A J, Cetkovic-Bakmas M G, Stöber G. Cycloid psychoses - from clinical concepts to biological foundations.  J Neural Transm. 2002;  109 907-919
• 9 Krüger E, Grube M, Hartwich P. Acute paranoid hallucinatory psychosis following mefloquine prophylaxis (Lariam).  Psychiatr Prax. 1999;  26 252-254
• 10 Leonhard K. Aufteilung der endogenen Psychosen und ihre differenzierte Ätiologie. In Beckmann H, Editor 8. Auflage Stuttgart, New York; Thieme 2003
• 11 Little J D, Ungvari G, McFarlane J. Successful ECT in a case of Leonhard’s cycloid psychosis.  J ECT. 2000;  16 62-67
• 12 Pfuhlmann B. Das Konzept der zykloiden Psychosen. Entwicklung, klinischer Stellenwert und derzeitiger Stand der Forschung.  Fortschr Neurol Psychiatr. 1998;  66 1-9
• 13 Reischies F M, Hartikkainen J, Berghöfer A M. Initial triple therapy of acute mania, adding lithium and valproat to neuroleptics.  Pharmacopsychiatry. 2002;  35 244-246
• 14 Sackeim H A, Prudic J, Devanand D P, Kiersky J E, Fitzsimons L, Moody B J, McElhiney M C, Coleman E A, Settembrino J M. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy.  N Engl J Med. 1993;  328 839-846
• 15 Strik W K, Dierks T, Franzek E, Maurer K, Beckmann H. Differences in P300 amplitudes and topography between cycloid psychoses and schizophrenia in Leonhard’s classification.  Acta Psychiatr Scand. 1993;  87 179-183
• 16 Strik W K, Fallgatter A J, Stoeber G, Franzek E, Beckmann H. Specific P300 features in patients with cycloid psychoses.  Acta Psychiatr Scand. 1996;  94 471-476
• 17 World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines. 10th edition Geneva; World Health Organization 1992